{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:59:06Z","timestamp":1788245946270,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","award":["0174-00051A"],"award-info":[{"award-number":["0174-00051A"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-53237-x","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:02:54Z","timestamp":1730106174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["ClC-1 Inhibition as a Mechanism for Accelerating Skeletal Muscle Recovery After Neuromuscular Block in Rats"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9420-5143","authenticated-orcid":false,"given":"Marianne","family":"Skals","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8962-2505","authenticated-orcid":false,"given":"Martin","family":"Broch-Lips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4449-472X","authenticated-orcid":false,"given":"Martin Brandh\u00f8j","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Riisager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Ceelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole B\u00e6kgaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-2590","authenticated-orcid":false,"given":"Sorin J.","family":"Brull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0490-2074","authenticated-orcid":false,"given":"Hans D.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1060-4989","authenticated-orcid":false,"given":"Thomas Holm","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"53237_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00000542-200502000-00005","volume":"102","author":"MS Arbous","year":"2005","unstructured":"Arbous, M. S. et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 102, 257\u2013268 (2005).","journal-title":"Anesthesiology"},{"key":"53237_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bjae.2020.03.008","volume":"20","author":"JM Hunter","year":"2020","unstructured":"Hunter, J. M. Reversal of neuromuscular block. BJA Educ. 20, 259\u2013265 (2020).","journal-title":"BJA Educ"},{"key":"53237_CR3","doi-asserted-by":"publisher","first-page":"109818","DOI":"10.1016\/j.jclinane.2020.109818","volume":"64","author":"AD Raval","year":"2020","unstructured":"Raval, A. D., Uyei, J., Karabis, A., Bash, L. D. & Brull, S. J. Incidence of residual neuromuscular blockade and use of neuromuscular blocking agents with or without antagonists: A systematic review and meta-analysis of randomized controlled trials. J Clin. Anesth 64, 109818 (2020).","journal-title":"J Clin. Anesth"},{"key":"53237_CR4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1399-6576.1997.tb04851.x","volume":"41","author":"H Berg","year":"1997","unstructured":"Berg, H. et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 41, 1095\u20131103 (1997).","journal-title":"Acta Anaesthesiol Scand"},{"key":"53237_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/ALN.0000000000001279","volume":"125","author":"CM Bulka","year":"2016","unstructured":"Bulka, C. M. et al. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia. Anesthesiology 125, 647\u2013655 (2016).","journal-title":"Anesthesiology"},{"key":"53237_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1213\/ane.0b013e31816d1268","volume":"107","author":"GS Murphy","year":"2008","unstructured":"Murphy, G. S. et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 107, 130\u2013137 (2008).","journal-title":"Anesth Analg"},{"key":"53237_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/bja\/aex002","volume":"118","author":"A Miskovic","year":"2017","unstructured":"Miskovic, A. & Lumb, A. B. Postoperative pulmonary complications. Br J Anaesth 118, 317\u2013334 (2017).","journal-title":"Br J Anaesth"},{"key":"53237_CR8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/00000542-200004000-00014","volume":"92","author":"E Sundman","year":"2000","unstructured":"Sundman, E. et al. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 92, 977\u2013984 (2000).","journal-title":"Anesthesiology"},{"key":"53237_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1164\/rccm.200512-1862OC","volume":"175","author":"M Eikermann","year":"2007","unstructured":"Eikermann, M. et al. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Crit Care Med. 175, 9\u201315 (2007).","journal-title":"Am J Respir Crit Care Med"},{"key":"53237_CR10","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/00000542-199711000-00005","volume":"87","author":"LI Eriksson","year":"1997","unstructured":"Eriksson, L. I. et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 87, 1035\u20131043 (1997).","journal-title":"Anesthesiology"},{"key":"53237_CR11","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1097\/ALN.0b013e3181fc6e0a","volume":"113","author":"J Canet","year":"2010","unstructured":"Canet, J. et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology 113, 1338\u20131350 (2010).","journal-title":"Anesthesiology"},{"key":"53237_CR12","doi-asserted-by":"crossref","unstructured":"Cammu, G. Residual Neuromuscular Blockade and Postoperative Pulmonary Complications: What Does the Recent Evidence Demonstrate? Curr Anesthesiol Rep. 1-6 (2020).","DOI":"10.1007\/s40140-020-00388-4"},{"key":"53237_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/EJA.0000000000001769","volume":"40","author":"T Fuchs-Buder","year":"2023","unstructured":"Fuchs-Buder, T. et al. Peri-operative management of neuromuscular blockade: A guideline from the European Society of Anaesthesiology and Intensive Care. Eur J Anaesthesiol. 40, 82\u201394 (2023).","journal-title":"Eur J Anaesthesiol"},{"key":"53237_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.17085\/apm.21014","volume":"16","author":"W Lee","year":"2021","unstructured":"Lee, W. The latest trend in neuromuscular monitoring: return of the electromyography. Anesth Pain Med (Seoul) 16, 133\u2013137 (2021).","journal-title":"Anesth Pain Med (Seoul)"},{"key":"53237_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/ALN.0000000000001409","volume":"126","author":"SJ Brull","year":"2017","unstructured":"Brull, S. J. & Kopman, A. F. Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities. Anesthesiology 126, 173\u2013190 (2017).","journal-title":"Anesthesiology"},{"key":"53237_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/00000542-200305000-00002","volume":"98","author":"LI Eriksson","year":"2003","unstructured":"Eriksson, L. I. Evidence-based practice and neuromuscular monitoring: it\u2019s time for routine quantitative assessment. Anesthesiology 98, 1037\u20131039 (2003).","journal-title":"Anesthesiology"},{"key":"53237_CR17","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/aas.14279","volume":"67","author":"T Fuchs-Buder","year":"2023","unstructured":"Fuchs-Buder, T. et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents III: The 2023 Geneva revision. Acta Anaesthesiol Scand 67, 994\u20131017 (2023).","journal-title":"Acta Anaesthesiol Scand"},{"key":"53237_CR18","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1152\/japplphysiol.00402.2017","volume":"123","author":"KE Kowalski","year":"2017","unstructured":"Kowalski, K. E., Romaniuk, J. R., Kowalski, T. & DiMarco, A. F. Effects of expiratory muscle activation via high-frequency spinal cord stimulation. J Appl. Physiol. (1985) 123, 1525\u20131531 (2017).","journal-title":"J Appl. Physiol. (1985)"},{"key":"53237_CR19","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1097\/ALN.0b013e31819faa71","volume":"110","author":"F Herbstreit","year":"2009","unstructured":"Herbstreit, F., Peters, J. & Eikermann, M. Impaired upper airway integrity by residual neuromuscular blockade: increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 110, 1253\u20131260 (2009).","journal-title":"Anesthesiology"},{"key":"53237_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00000542-200501000-00011","volume":"102","author":"A Samet","year":"2005","unstructured":"Samet, A., Capron, F., Alla, F., Meistelman, C. & Fuchs-Buder, T. Single acceleromyographic train-of-four, 100-Hertz tetanus or double-burst stimulation: which test performs better to detect residual paralysis? Anesthesiology 102, 51\u201356 (2005).","journal-title":"Anesthesiology"},{"key":"53237_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1213\/00000539-199807000-00038","volume":"87","author":"MJ Baurain","year":"1998","unstructured":"Baurain, M. J. et al. Visual evaluation of residual curarization in anesthetized patients using one hundred-hertz, five-second tetanic stimulation at the adductor pollicis muscle. Anesth Analg 87, 185\u2013189 (1998).","journal-title":"Anesth Analg"},{"key":"53237_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1399-6576.2006.01228.x","volume":"51","author":"M Eikermann","year":"2007","unstructured":"Eikermann, M., Gerwig, M., Hasselmann, C., Fiedler, G. & Peters, J. Impaired neuromuscular transmission after recovery of the train-of-four ratio. Acta Anaesthesiol Scand 51, 226\u2013234 (2007).","journal-title":"Acta Anaesthesiol Scand"},{"key":"53237_CR23","doi-asserted-by":"crossref","unstructured":"Dubois, P. E. et al. The interest of 100 versus 200 Hz tetanic stimulations to quantify low levels of residual neuromuscular blockade with mechanomyography: a pilot study. J Clin Monit Comput (2021).","DOI":"10.1007\/s10877-021-00745-6"},{"key":"53237_CR24","doi-asserted-by":"publisher","first-page":"100903","DOI":"10.1016\/j.accpm.2021.100903","volume":"40","author":"B Debaene","year":"2021","unstructured":"Debaene, B., Frasca, D., Moreillon, F. & D\u2019Hollander, A. A. 100 Hz-5 s tetanic stimulation to illustrate the presence of \u201cresidual paralysis\u201d co-existing with accelerometric 0.90 train-of-four ratio-A proof-of-concept study. Anaesth Crit Care Pain Med. 40, 100903 (2021).","journal-title":"Anaesth Crit Care Pain Med"},{"key":"53237_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/ALN.0000000000004379","volume":"138","author":"SR Thilen","year":"2023","unstructured":"Thilen, S. R. et al. 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology 138, 13\u201341 (2023).","journal-title":"Anesthesiology"},{"key":"53237_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/bja\/ael013","volume":"96","author":"HD de Boer","year":"2006","unstructured":"de Boer, H. D., van Egmond, J., van de Pol, F., Bom, A. & Booij, L. H. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey. Br J Anaesth 96, 473\u2013479 (2006).","journal-title":"Br J Anaesth"},{"key":"53237_CR27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/bja\/aes137","volume":"109","author":"K Godai","year":"2012","unstructured":"Godai, K. et al. Three cases of suspected sugammadex-induced hypersensitivity reactions. Br J Anaesth 109, 216\u2013218 (2012).","journal-title":"Br J Anaesth"},{"key":"53237_CR28","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1097\/ALN.0000000000000868","volume":"123","author":"F Haerter","year":"2015","unstructured":"Haerter, F. et al. Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents. Anesthesiology 123, 1337\u20131349 (2015).","journal-title":"Anesthesiology"},{"key":"53237_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/ALN.0b013e3182910213","volume":"119","author":"U Hoffmann","year":"2013","unstructured":"Hoffmann, U. et al. Calabadion: A new agent to reverse the effects of benzylisoquinoline and steroidal neuromuscular-blocking agents. Anesthesiology 119, 317\u2013325 (2013).","journal-title":"Anesthesiology"},{"key":"53237_CR30","doi-asserted-by":"crossref","unstructured":"Pedersen, T. H., Macdonald, W. A., Broch-Lips, M., Halldorsdottir, O. & Baekgaard Nielsen, O. Chloride channel inhibition improves neuromuscular function under conditions mimicking neuromuscular disorders. Acta Physiol. (Oxf), e13690 (2021).","DOI":"10.1111\/apha.13690"},{"key":"53237_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk9109","volume":"16","author":"M Skov","year":"2024","unstructured":"Skov, M. et al. The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis. Sci Transl Med. 16, eadk9109 (2024).","journal-title":"Sci Transl Med"},{"key":"53237_CR32","unstructured":"Knutsen, L. J. K., Kelly, N., Skov, M. B., Riisager, A., Saraswat, N. Compounds for the treatment of neuromuscular disorders, Patent application WO2020\/254559. (2020)."},{"key":"53237_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1085\/jgp.201611582","volume":"147","author":"TH Pedersen","year":"2016","unstructured":"Pedersen, T. H., Riisager, A., de Paoli, F. V., Chen, T. Y. & Nielsen, O. B. Role of physiological ClC-1 Cl- ion channel regulation for the excitability and function of working skeletal muscle. J Gen Physiol. 147, 291\u2013308 (2016).","journal-title":"J Gen Physiol"},{"key":"53237_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1085\/jgp.200910291","volume":"134","author":"TH Pedersen","year":"2009","unstructured":"Pedersen, T. H., Macdonald, W. A., de Paoli, F. V., Gurung, I. S. & Nielsen, O. B. Comparison of regulated passive membrane conductance in action potential-firing fast- and slow-twitch muscle. J Gen. Physiol. 134, 323\u2013337 (2009).","journal-title":"J Gen. Physiol."},{"key":"53237_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nmd.2024.01.007","volume":"36","author":"JB Winther","year":"2024","unstructured":"Winther, J. B. et al. Role of recovery of acetylcholine release in compromised neuromuscular junction function. Neuromuscul Disord 36, 48\u201359 (2024).","journal-title":"Neuromuscul Disord"},{"key":"53237_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuropharm.2012.09.006","volume":"65","author":"JF Desaphy","year":"2013","unstructured":"Desaphy, J. F., Costanza, T., Carbonara, R. & Conte Camerino, D. In vivo evaluation of antimyotonic efficacy of beta-adrenergic drugs in a rat model of myotonia. Neuropharmacology 65, 21\u201327 (2013).","journal-title":"Neuropharmacology"},{"key":"53237_CR37","doi-asserted-by":"publisher","first-page":"100917","DOI":"10.1016\/j.accpm.2021.100917","volume":"40","author":"T Fuchs-Buder","year":"2021","unstructured":"Fuchs-Buder, T. & Schmartz, D. Making the invisible apparent: 100-Hz, 5-s tetanic stimulation to detect residual paralysis. Anaesth Crit Care Pain Med. 40, 100917 (2021).","journal-title":"Anaesth Crit Care Pain Med"},{"key":"53237_CR38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1213\/00000539-198205000-00009","volume":"61","author":"AF Kopman","year":"1982","unstructured":"Kopman, A. F., Epstein, R. H. & Flashburg, M. H. Use of 100-Hertz tetanus as an index of recovery from pancuronium-induced non-depolarizing neuromuscular blockade. Anesth Analg 61, 439\u2013441 (1982).","journal-title":"Anesth Analg"},{"key":"53237_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1365-2044.1989.tb11280.x","volume":"44","author":"DR Goldhill","year":"1989","unstructured":"Goldhill, D. R., Wainwright, A. P., Stuart, C. S. & Flynn, P. J. Neostigmine after spontaneous recovery from neuromuscular blockade. Effect on depth of blockade monitored with train-of-four and tetanic stimuli. Anaesthesia 44, 293\u2013299 (1989).","journal-title":"Anaesthesia"},{"key":"53237_CR40","first-page":"113","volume":"33","author":"MJ Fogarty","year":"2018","unstructured":"Fogarty, M. J., Mantilla, C. B. & Sieck, G. C. Breathing: Motor Control of Diaphragm Muscle. Physiology (Bethesda) 33, 113\u2013126 (2018).","journal-title":"Physiology (Bethesda)"},{"key":"53237_CR41","first-page":"559","volume":"136","author":"C Huang","year":"2023","unstructured":"Huang, C. et al. Sugammadex Versus Neostigmine for Recovery of Respiratory Muscle Strength Measured by Ultrasonography in the Postextubation Period: A Randomized Controlled Trial. Anesth Analg 136, 559\u2013568 (2023).","journal-title":"Anesth Analg"},{"key":"53237_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/0009-9236(95)90190-6","volume":"58","author":"RM Welch","year":"1995","unstructured":"Welch, R. M., Brown, A., Ravitch, J. & Dahl, R. The in vitro degradation of cisatracurium, the R, cis-R\u2019-isomer of atracurium, in human and rat plasma. Clin Pharmacol. Ther 58, 132\u2013142 (1995).","journal-title":"Clin Pharmacol. Ther"},{"key":"53237_CR43","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1113\/jphysiol.2014.280529","volume":"592","author":"A Riisager","year":"2014","unstructured":"Riisager, A., Duehmke, R., Nielsen, O. B., Huang, C. L. & Pedersen, T. H. Determination of cable parameters in skeletal muscle fibres during repetitive firing of action potentials. J Physiol. 592, 4417\u20134429 (2014).","journal-title":"J Physiol"},{"key":"53237_CR44","first-page":"425","volume":"32","author":"O Baekgaard Nielsen","year":"2017","unstructured":"Baekgaard Nielsen, O., de Paoli, F. V., Riisager, A. & Pedersen, T. H. Chloride Channels Take Center Stage in Acute Regulation of Excitability in Skeletal Muscle: Implications for Fatigue. Physiology (Bethesda) 32, 425\u2013434 (2017).","journal-title":"Physiology (Bethesda)"},{"key":"53237_CR45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/mus.25064","volume":"54","author":"JS Bayley","year":"2016","unstructured":"Bayley, J. S., Pedersen, T. H. & Nielsen, O. B. Skeletal muscle dysfunction in the db\/db mouse model of type 2 diabetes. Muscle Nerve 54, 460\u2013468 (2016).","journal-title":"Muscle Nerve"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53237-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53237-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53237-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:03:03Z","timestamp":1730106183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53237-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53237"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-53237-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4157720\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"3 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studies were sponsored by NMD Pharma. Marianne Skals, Martin Broch-Lips, Martin Brandh\u00f8j Skov, Anders Riisager, Judith Ceelen, Ole B\u00e6kgaard Nielsen and Thomas Holm Pedersen were or are employed by NMD Pharma A\/S and may own and\/or hold options\/restricted stock units for the company and\/or patents on the designed compounds. Hans D. de Boer is member of the Global Advisory Board of Merck & Co. (Kenilworth, NJ, USA), member of the Scientific Advisory Board of Senzime (Uppsala, Sweden), member of the Global Advisory Board of NMD Pharma (Aarhus, Denmark), Chairman of the Dutch Society for Enhanced Recovery After Surgery and founder of ERASNextGen\u00ae. Sorin J. Brull has intellectual property assigned to Mayo Clinic (Rochester, MN); was a consultant for Merck & Co., Inc. (Kenilworth, NJ, USA); is a principal, shareholder and Chief Medical Officer in Senzime AB (publ) (Uppsala, Sweden); and an unpaid member of the Scientific\/Clinical Advisory Boards for Coala Life Inc. (Irvine, CA); NMD Pharma (Aarhus, Denmark); and Takeda Pharmaceuticals (Cambridge, MA). The authors declare no other competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9289"}}